OPEN-LABEL
Clinical trials for OPEN-LABEL explained in plain language.
Never miss a new study
Get alerted when new OPEN-LABEL trials appear
Sign up with your email to follow new studies for OPEN-LABEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug takes aim at Hard-to-Treat sarcoma
Disease control Not yet recruitingThis early-stage trial is testing a new drug called REC-617 in 15 people with a rare type of sarcoma (leiomyosarcoma) that has spread or cannot be removed and has not responded to prior treatments. The drug targets a protein (CDK7) that helps cancer cells grow. The main goal is t…
Matched conditions: OPEN-LABEL
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New vaginal capsule aims to tackle stubborn bacterial vaginosis
Disease control Not yet recruitingThis study tests a new drug called GenSci142, given as a vaginal capsule, for treating bacterial vaginosis (BV). About 30 women with BV will receive either GenSci142 or a standard antibiotic cream to compare safety and how well each works. The goal is to see if the new capsule is…
Matched conditions: OPEN-LABEL
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC